Alan G. Casson

6.7k total citations
103 papers, 4.3k citations indexed

About

Alan G. Casson is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Alan G. Casson has authored 103 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Surgery, 42 papers in Pulmonary and Respiratory Medicine and 31 papers in Molecular Biology. Recurrent topics in Alan G. Casson's work include Esophageal Cancer Research and Treatment (52 papers), Esophageal and GI Pathology (28 papers) and Gastric Cancer Management and Outcomes (20 papers). Alan G. Casson is often cited by papers focused on Esophageal Cancer Research and Treatment (52 papers), Esophageal and GI Pathology (28 papers) and Gastric Cancer Management and Outcomes (20 papers). Alan G. Casson collaborates with scholars based in Canada, United States and United Kingdom. Alan G. Casson's co-authors include Geoffrey A. Porter, Paul J. Veugelers, Jack A. Roth, Tapas Mukhopadhyay, Jae Y. Ro, Duane L. Guernsey, Frances P. O’Malley, Ann F. Chambers, S. Jane Darnton and Ronghua Zhao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Alan G. Casson

103 papers receiving 4.2k citations

Peers

Alan G. Casson
Rebecca A. Nelson United States
Alan G. Casson
Citations per year, relative to Alan G. Casson Alan G. Casson (= 1×) peers Rebecca A. Nelson

Countries citing papers authored by Alan G. Casson

Since Specialization
Citations

This map shows the geographic impact of Alan G. Casson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan G. Casson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan G. Casson more than expected).

Fields of papers citing papers by Alan G. Casson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan G. Casson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan G. Casson. The network helps show where Alan G. Casson may publish in the future.

Co-authorship network of co-authors of Alan G. Casson

This figure shows the co-authorship network connecting the top 25 collaborators of Alan G. Casson. A scholar is included among the top collaborators of Alan G. Casson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan G. Casson. Alan G. Casson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Ronghua, Luca Quaroni, & Alan G. Casson. (2012). Identification and characterization of stemlike cells in human esophageal adenocarcinoma and normal epithelial cell lines. Journal of Thoracic and Cardiovascular Surgery. 144(5). 1192–1199. 26 indexed citations
2.
Liao, Linda M., Thomas L. Vaughan, Douglas A. Corley, et al.. (2011). Nonsteroidal Anti-inflammatory Drug Use Reduces Risk of Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis. Gastroenterology. 142(3). 442–452.e5. 124 indexed citations
3.
Nguyen, Giang Huong, Aaron J. Schetter, David B. Chou, et al.. (2010). Inflammatory and MicroRNA Gene Expression as Prognostic Classifier of Barrett's-Associated Esophageal Adenocarcinoma. Clinical Cancer Research. 16(23). 5824–5834. 58 indexed citations
4.
Mathé, Ewy A., Giang Huong Nguyen, Elise D. Bowman, et al.. (2009). MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival. Clinical Cancer Research. 15(19). 6192–6200. 319 indexed citations
5.
Balbuena, Lloyd & Alan G. Casson. (2009). Dietary folate and vitamin B6 are not associated with p53 mutations in esophageal adenocarcinoma. Molecular Carcinogenesis. 49(3). 211–214. 3 indexed citations
6.
Geldenhuys, Laurette, et al.. (2009). Regulation of CDX2 expression in esophageal adenocarcinoma. Molecular Carcinogenesis. 48(10). 965–974. 23 indexed citations
7.
Darling, Gail, David T. Eton, Joanne Sulman, Alan G. Casson, & David Cella. (2006). Validation of the functional assessment of cancer therapy esophageal cancer subscale. Cancer. 107(4). 854–863. 72 indexed citations
8.
Evans, Susan C., Amy Gillis, Laurette Geldenhuys, et al.. (2004). Microsatellite instability in esophageal adenocarcinoma. Cancer Letters. 212(2). 241–251. 24 indexed citations
9.
Casson, Alan G.. (2002). Role of molecular biology in the follow-up of patients who have Barrett's esophagus. Chest Surgery Clinics of North America. 12(1). 93–111. 16 indexed citations
10.
Casson, Alan G., S. Jane Darnton, Sujata Subramanian, & Louise Hiller. (2000). What is the optimal distal resection margin for esophageal carcinoma?. The Annals of Thoracic Surgery. 69(1). 205–209. 52 indexed citations
11.
Guyatt, Gordon, Lauren E. Griffith, John D. Miller, et al.. (1999). Surgeons’ assessment of symptoms suggesting extrathoracic metastases in patients with lung cancer. The Annals of Thoracic Surgery. 68(2). 309–315. 12 indexed citations
12.
Sanders, D. S. A., et al.. (1998). Sequential changes in cadherin‐catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma. International Journal of Cancer. 79(6). 573–579. 3 indexed citations
13.
Sanders, D. S. A., et al.. (1998). Sequential changes in cadherin-catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma. International Journal of Cancer. 79(6). 573–579. 43 indexed citations
14.
Schneider, Paul M., Alan G. Casson, Bernard Levin, et al.. (1996). Mutations of p53 in barrett's esophagus and barrett's cancer: A prospective study of ninety-eight cases. Journal of Thoracic and Cardiovascular Surgery. 111(2). 323–333. 92 indexed citations
15.
Casson, Alan G. & J. Andrea McCart. (1995). GENETIC MODULATION IN THE PATHOGENESIS AND TREATMENT OF CANCER. Chest Surgery Clinics of North America. 5(1). 17–37. 4 indexed citations
16.
Maziak, Donna E., Michael R. Johnston, & Alan G. Casson. (1995). Adenocarcinoma of the neo-esophagus after collis gastroplasty. The Annals of Thoracic Surgery. 60(6). 1795–1797. 4 indexed citations
17.
Casson, Alan G., Nancy Kerkvliet, Frances P. O’Malley, Richard Inculet, & Michael Troster. (1994). P53 immunoreactivity in carcinosarcoma of the esophagus. Journal of Surgical Oncology. 56(2). 132–135. 9 indexed citations
18.
Casson, Alan G., Tapas Mukhopadhyay, Karen R. Cleary, et al.. (1991). Oncogene activation in esophageal cancer. Journal of Thoracic and Cardiovascular Surgery. 102(5). 707–709. 14 indexed citations
19.
Casson, Alan G., Richard Inculet, & Richard J. Finley. (1991). Volvulus of the intrathoracic stomach after total esophagectomy. Journal of Thoracic and Cardiovascular Surgery. 102(4). 641–641. 1 indexed citations
20.
Casson, Alan G., et al.. (1984). Retinoblastoma, eosinophilic granuloma, and malignant melanoma: A case report. Medical and Pediatric Oncology. 12(5). 347–348. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026